| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Recent advancements in product development highlight a strong focus on innovation and improving customer experience. The successful launch of new health products, such as Genentech's Fenebrutinib, reflects a commitment to addressing market needs effectively. Additionally, features like FanDuel's jackpot enhancement showcase the drive to attract and retain customers. Overall, these efforts indicate a positively evolving landscape in product and service offerings. |
| The price action of The Progressive Corporation (PGR) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.5 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for PGR since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.5, and the negative at 0 on 2025-11-10. The forces of and () will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), Valuation Sentiment (0.5), and Sentiment towards Fundamentals (2.6) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| PGR | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-10 | 0%(0%) | 0 | 0% | 0.5 | 2.6 | -1 | |||||||
| 2025-11-09 | 0%(0%) | 0 | 0% | 0.3 | 1.4 | -1 | |||||||
| 2025-11-08 | 0%(0%) | 0 | 0% | 0.3 | 1.4 | 7 | |||||||
| 2025-11-07 | 0%(0%) | 0 | 0% | 0.1 | 1.8 | -1 | |||||||
| 2025-11-06 | 0%(0%) | 0 | 0% | -0 | 0.8 | -1 | |||||||
| 2025-11-05 | 0%(0%) | 0 | 0% | -0.1 | 0.4 | -1 | |||||||
| 2025-11-04 | 0%(0%) | 0 | 0% | -0.2 | -0.3 | -1 | |||||||
| 2025-11-03 | 0%(0%) | 0 | 0% | -0.2 | -0.3 | -1 | |||||||
| 2025-11-02 | 0%(0%) | 0 | 0% | -0.2 | -0.2 | -1 | |||||||
| 2025-11-01 | 0%(0%) | 0 | 0% | -0.4 | -1.1 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-11-10 17:07:20 The financial support and investment activities leading to advancements and product development in biotechnology firms. |
| 2025-11-10 17:07:20 The strategic benefits companies like Genentech may gain from developing unique products that address unmet medical needs in the market. |
| 2025-11-10 17:07:20 Emerging trends in the pharmaceutical industry, particularly the shift towards innovative treatments like BTK inhibitors for chronic conditions. |
| 2025-11-10 17:07:20 The advancement of new health products, notably Genentech's Fenebrutinib, which shows promising results in clinical trials. |
| 2025-11-10 17:07:20 The performance of stocks in the market, with a focus on gains and losses, as exemplified by the Progressive Corporation's slight increase. |